BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Leinco Technologies And CellCarta Partner To Advance Proteomics In Immuno Oncology

Leinco Technologies, a leader in antibody and protein development, and CellCarta, a global provider of precision medicine laboratory services, are ple...

April 22, 2026 | News

Biogen Inc. Secures Global Rights To Felzartamab Through Greater China Deal With TJ Biopharma

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one...

April 22, 2026 | News

Mabwell Secures JFDA GMP Compliance For Denosumab Biosimilars, Marking PIC S Milestone

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-m...

April 22, 2026 | News

Orthogon Therapeutics Secures 11 Million Dollars To Advance First In Class Oral Therapy For BK Virus In Transplant Patients

Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...

April 21, 2026 | News

EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study

First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...

April 21, 2026 | News

Synthetic Design Lab Introduces Logic Gated SYNTHBODY Platform Redefining Precision Protein Therapeutics

SYNTHBODY™ introduces a new class of “smart drugs”: protein therapeutics with built-in, multi-layered logic gates that actively chang...

April 20, 2026 | News

Mabwell Advances Alpha Synuclein PET Tracer Into Phase I Strengthening Early Diagnosis Of Neurodegenerative Disorders

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST0...

April 16, 2026 | News

WuXi Biologics Secures ISO 13485 Certification With Zero Non Conformities Strengthening Combination Product Capabilities

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has successfully ...

April 16, 2026 | News

Kazia Therapeutics Expands Oncology Pipeline With SETDB1 Targeted Epigenetic Platform

Kazia Therapeutics Limited (Nasdaq: KZIA), a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment re...

April 15, 2026 | News

Lynk Pharmaceuticals Secures China NDA Acceptance For Zemprocitinib In Atopic Dermatitis

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammat...

April 13, 2026 | News

Ascletis Pharma Inc. Advances Oral GLP 1 And Amylin Combination For Obesity Treatment

-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in...

April 09, 2026 | News

Singlomics Biopharmaceuticals Doses First Patient In Phase I Trial Of DXP 106 Antibody

Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for...

April 09, 2026 | News

Toshiba Corporation Advances Quantum Inspired Computing With 100 Fold Faster Optimisation Algorithm

Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprie...

April 08, 2026 | News

Perceptive Discovery Expands In Vitro Capabilities To Accelerate Oncology Drug Development

Perceptive Discovery, a leading scientific partner to the global biopharmaceutical industry, announced a major expansion of its in vitro laboratory capabil...

April 07, 2026 | News

Stay Connected